Kratom Use Disorder Management Using Clonidine and/or Buprenorphine

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age20-99
SponsorSalem Anaesthesia Pain Clinic

About this trial

Kratom is used for stimulant, analgesic, anxiolytic, and sedative effects. There is inadequate knowledge about Kratom addiction. Kratom withdrawal may be treated like opioid withdrawal.

Prospective observational crossover study of consenting adults who are undergoing Kratom withdrawal management. On alternate weeks, each patient receives treatment using Buprenorphine 5cmg/hr patch; or Clonidine tablet 0.1mg 4hourly; or combined Clonidine tablet 0.1mg 4hourly + Buprenorphine 5cmg/hr patch. Each patient will undergo treatment for 12 weeks.

Patients will use Subjective Opiate Withdrawal Scale (SOWS) to collect data on daily basis. SOWS is a patient-administered tool that is used to record the severity and presence of opiate withdrawal. The physician will also use Clinical Opiate Withdrawal Scale (COWS) to collect data on weekly basis. COWS is a clinician-administered tool that is used to record the signs of opiate withdrawal. A change in the COWS and SOWS scores by 6-points is considered significant.

Eligibility criteria

Qualifiers

adult patients

Kratom dependence

Kratom withdrawal syndrome

Kratom withdrawal therapy

Disqualifiers

poor treatment compliance

cognitive disorder

inability to provide consent

major neuropsychiatric disorder

Trial design

Treatments tested in this trial

  • Clonidine, Buprenorphine

Treatment groups

50 Participants
are divided into 1 treatment group

Sponsors and collaborators